ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
The Utilization and Outcomes of Inferior Vena Cava Filter Use.
Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulmonary Embolism Despite Inferior Vena Cava Filter in a Polytrauma Patient: A Case Report.Case reports in orthopedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThe utilization of inferior vena cava filters (IVCF) has evolved over time. We explored the indications, complications, and outcomes of patients undergoing IVCF placement.MethodsWe performed a single institution, retrospective review of CPT codes for IVCF placement between 2018 and 2022. Patient characteristics and location were collected. Indications for IVCF placement were categorized. Procedural details were noted and immediate and long-term complications. IVCF removal, total IVCF days, and removal complication were analyzed. Overall mortality, cause of death, and if death occurred the same admission were included.ResultsAn analysis of 347 patients undergoing IVCF placement was performed. Mean patient age was 65 years-old (+/- 16 years), 167 patients (48%) were male, and 28% with current malignancy at time of IVCF placement. 8% of patients had prior DVT, 22% prior PE, 3% prior IVCF. 84% were inpatient on floors, 12% in the ICU, and 4% ambulatory. IVCF were typically placed prior to a surgery with contraindication to anticoagulation (41%), gastrointestinal bleed (15%), failure of anticoagulation (10%), brain bleed (9%), and during venous thrombectomy (8%). The operations included spine procedures (17%) other orthopedic procedures (19%), abdominal procedures (32%), and bariatric interventions (6%). Retrievable filters were placed in 99% of patients. Immediate postoperative complications occurred in 6% of patients. Worsening edema within the same admission, DVT, and filter strut migration in 12% of patients. 29% of patients underwent IVCF removal, of which 10 were unsuccessful and resulted in the filter remaining in place despite an attempt to retrieve it. All-cause mortality at any time point was 21%, with 42% of mortalities occurring during the same admission as the IVC filter placement. Of these mortalities, 4 (1.2%) were secondary to VTE complications. Mortality at 30 days was 8.3% and at 1 year was 15.7%. Death during the admission of IVC filter placement was positively correlated with older age (p = 0.010) and current malignancy was associated with higher mortality (OR 2.2, p < 0.001). Spine surgery patients were 3.8 times more likely to undergo IVCF removal (p = 0.002) as well as patients undergoing ambulatory IVCF placement (p = 0.001).ConclusionIVCF placement has utility in younger patients undergoing elective operations, particularly spine procedures, with contraindication to anticoagulation. Older patients and those with current malignancy are unlikely to benefit given the higher mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.